Previous close | 1,194.00 |
Open | 1,212.00 |
Bid | 1,207.00 x N/A |
Ask | 1,210.00 x N/A |
Day's range | 1,202.00 - 1,218.00 |
52-week range | 779.00 - 1,218.00 |
Volume | |
Avg. volume | 79,543 |
Market cap | 3.004B |
Beta (5Y monthly) | 0.62 |
PE ratio (TTM) | 2,366.67 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.32 (2.69%) |
Ex-dividend date | 30 May 2024 |
1y target est | N/A |
Key Insights Britvic's estimated fair value is UK£18.63 based on 2 Stage Free Cash Flow to Equity Britvic is estimated...
Britvic had rejected a 3.11 billion pound takeover proposal from Carlsberg last week. Carlsberg is considering its options and said on Monday that PepsiCo agreed to waive a clause in its bottling deal with Britvic, in a move that could pave the way for the Danish firm to raise its bid for the maker of Robinsons fruit cordial. The company will evaluate recommencement of the share repurchase programme should the circumstances change, it said.
The NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against Respiratory Syncytial Virus (RSV), the winter infection known as the “silent killer” of the elderly.